Feasibility of assessing comparative long-term safety for gene therapy products by creating an external control arm using real-world data sources

被引：0
|
作者：
Vossen, Carla Y. [1 ]
Madaj, Keely [1 ]
Menon, Jyothi [1 ]
Albano, Jessica D. [1 ]
机构：
[1] Syneos Hlth, Bridgewater, NJ USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
655
引用
收藏
页码：307 / 308
页数：2
相关论文
共 50 条
  • [21] Evaluation of long-term outcomes of icatibant using real-world data from the Icatibant Outcome Survey
    Laffan, J.
    Longhurst, H.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Maurer, M.
    Fabien, V.
    Andresen, I.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (12): : 1887 - 1887
  • [22] Long-term effectiveness and safety of growth hormone therapy in Japanese children with short stature due to Noonan syndrome (NS): real-world data
    Muroya, Koji
    Kawai, Masanobu
    Yamagishi, Hiroyuki
    Endo, Takaaki
    Pietropoli, Alberto
    Horikawa, Reiko
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 283 - 283
  • [23] Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
    Karolina Piejko
    Bożena Cybulska-Stopa
    Marcin Ziętek
    Robert Dziura
    Łukasz Galus
    Natasza Kempa-Kamińska
    Barbara Ziółkowska
    Ewa Rutkowska
    Tomasz Kopciński
    Tomasz Kubiatowski
    Wiesław Bal
    Rafał Suwiński
    Jacek Mackiewicz
    Grażyna Kamińska-Winciorek
    Anna M. Czarnecka
    Piotr Rutkowski
    Targeted Oncology, 2023, 18 : 235 - 245
  • [24] Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice
    Shear, N. H.
    Hartmann, M.
    Toledo-Bahena, M.
    Katsambas, A.
    Connors, L.
    Chang, Q.
    Yao, R.
    Nograles, K.
    Popmihajlov, Z.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : 631 - 641
  • [25] Real-World Data in Children with Spinal Muscular Atrophy Type 1 on Long-Term Ventilation Receiving Gene Therapy: A Prospective Cohort Study
    Alajjuri, Mohammad Ala'
    Abusamra, Rania
    Mundada, Vivek
    Narayan, Omendra
    ADVANCES IN RESPIRATORY MEDICINE, 2024, 92 (05) : 338 - 347
  • [26] Long-Term Real-World Safety and Efficacy of Liver-Directed AAV Gene Therapy for Severe Hemophilia with and without Inbibitors in Privately Owned Dogs
    Doshi, Bhavya S.
    Samelson-Jones, Ben J.
    Nichols, Timothy C.
    Merricks, Elizabeth P.
    Arruda, Valder R.
    Callan, Mary Beth
    BLOOD, 2022, 140 : 7780 - 7781
  • [27] Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma
    Alvarez, Javier Sanchez
    Jaber, Mahmoud
    Zumofen, Marie-Helene Blanchet
    ONCOLOGY AND THERAPY, 2023, 11 (04) : 495 - 511
  • [28] Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma
    Javier Sanchez Alvarez
    Mahmoud Jaber
    Marie-Hélène Blanchet Zumofen
    Oncology and Therapy, 2023, 11 : 495 - 511
  • [29] Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg)
    Krauss, Ekaterina
    Tello, Silke
    Wilhelm, Jochen
    Schmidt, Johanna
    Stoehr, Mark
    Seeger, Werner
    Dartsch, Ruth C.
    Crestani, Bruno
    Guenther, Andreas
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 19
  • [30] Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib plus Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
    Piejko, Karolina
    Cybulska-Stopa, Bozena
    Zietek, Marcin
    Dziura, Robert
    Galus, Lukasz
    Kempa-Kaminska, Natasza
    Ziolkowska, Barbara
    Rutkowska, Ewa
    Kopcinski, Tomasz
    Kubiatowski, Tomasz
    Bal, Wieslaw
    Suwinski, Rafal
    Mackiewicz, Jacek
    Kaminska-Winciorek, Grazyna
    Czarnecka, Anna M.
    Rutkowski, Piotr
    TARGETED ONCOLOGY, 2023, 18 (02) : 235 - 245
12345